Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer
Author:
Publisher
Springer Singapore
Link
http://link.springer.com/content/pdf/10.1007/978-981-10-6020-5_4
Reference278 articles.
1. Kalimutho M, Parsons K, Mittal D, Lopez JA, Srihari S, Khanna KK (2015) Targeted therapies for triple-negative breast cancer: combating a stubborn disease. Trends Pharmacol Sci 36(12):822–846. doi: 10.1016/j.tips.2015.08.009
2. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869–10874. doi: 10.1073/pnas.191367098
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752. doi: 10.1038/35021093
4. Rakha E, Ellis I, Reis-Filho J (2008) Are triple-negative and basal-like breast cancer synonymous? Clin Cancer Res 14(2):618.; author reply 618-619. doi: 10.1158/1078-0432.CCR-07-1943
5. Rakha EA, Tan DS, Foulkes WD, Ellis IO, Tutt A, Nielsen TO, Reis-Filho JS (2007) Are triple-negative tumours and basal-like breast cancer synonymous? Breast Cancer Res 9(6):404.; author reply 405. doi: 10.1186/bcr1827
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Differential Expression and Prognostic Significance of CDK1 and CDK6 in Breast Cancer: A Multi-Omics Approach;2024-08-11
2. Establishment of a humanized mouse model using steady‐state peripheral blood‐derived hematopoietic stem and progenitor cells facilitates screening of cancer‐targeted T‐cell repertoires;Cancer Innovation;2024-04-15
3. A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer;Bioorganic Chemistry;2024-02
4. ABCB1 Regulates Immune Genes in Breast Cancer;Breast Cancer: Targets and Therapy;2023-11
5. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line;PLOS ONE;2023-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3